US EditionTriSalus Life Sciences to Participate in Upcoming Investor Conferences
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
TriSalus Life Sciences to Participate in Upcoming Investor Conferences
WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences® Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients with solid tumors, today announced that Mary Szela, Chief Executive Officer and President, and David Patience, Chief Financial Officer, will participate in the following investor conferences [...] The post TriSa…
BILL to Participate in Upcoming Investor Conference
SAN JOSE, Calif.--(BUSINESS WIRE)--BILL (NYSE:BILL), the intelligent finance platform trusted by half a million businesses to manage, move and maximize their money, announced today its participation in Citi’s Annual FinTech Conference in New York on Tu... L'articolo BILL to Participate in Upcoming Investor Conference è un contenuto originale di 01net.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
